Research output per year
Research output per year
Personal profile
Research interests
The DeSelm lab studies cell therapy, specifically novel CAR myeloid and CAR T-cell therapies, in which immune cells are genetically modified to better recognize and eliminate cancer.
Clinical interests
Lymphoma, general radiation oncology.
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Carl DeSelm is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
BAP1 promotes osteoclast function by metabolic reprogramming
Rohatgi, N., Zou, W., Li, Y., Cho, K., Collins, P. L., Tycksen, E., Pandey, G., DeSelm, C. J., Patti, G. J., Dey, A. & Teitelbaum, S. L., Dec 2023, In: Nature communications. 14, 1, 5923.Research output: Contribution to journal › Article › peer-review
Open Access -
Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program
Price, A. T., Schiff, J. P., Laugeman, E., Maraghechi, B., Schmidt, M., Zhu, T., Reynoso, F., Hao, Y., Kim, T., Morris, E., Zhao, X., Hugo, G. D., Vlacich, G., DeSelm, C. J., Samson, P. P., Baumann, B. C., Badiyan, S. N., Robinson, C. G., Kim, H. & Henke, L. E., Sep 2023, In: Clinical and Translational Radiation Oncology. 42, 100661.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation
Kim, A. B., Chou, S. Y., Kang, S., Kwon, E., Inkman, M., Szymanski, J., Andruska, N., Colgan, C., Zhang, J., Yang, J. C., Singh, N. & DeSelm, C. J., Sep 26 2023, In: Blood Advances. 7, 18, p. 5396-5408 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
Jacobs, M. T., Wong, P., Zhou, A. Y., Becker-Hapak, M., Marin, N. D., Marsala, L., Foster, M., Foltz, J. A., Cubitt, C. C., Tran, J., Russler-Germain, D. A., Neal, C., Kersting-Schadek, S., Chang, L., Schappe, T., Pence, P., McClain, E., Zevallos, J. P., Rich, J. T., Paniello, R. C., & 7 others, Oct 15 2023, In: Clinical Cancer Research. 29, 20, p. 4196-4208 13 p.Research output: Contribution to journal › Article › peer-review
-
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
Faget, D. V., Luo, X., Inkman, M. J., Ren, Q., Su, X., Ding, K., Waters, M. R., Raut, G. K., Pandey, G., Dodhiawala, P. B., Ramalho-Oliveira, R., Ye, J., Cole, T., Murali, B., Zheleznyak, A., Shokeen, M., Weiss, K. R., Monahan, J. B., Deselm, C. J., Lee, A. V., & 5 others, Jun 1 2023, In: Cancer discovery. 13, 6, p. 1454-1477 24 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations